Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Fair Isaac Joins S&P's Top Ten


On July 10, Standard & Poor's equity research group made changes to the S&P Top 10 portfolio -- those issues it considers to be the best candidates for capital gains over the next 6 to 12 months. S&P replaced e-commerce concern InterActive Corp. (IACI) with Fair Isaac (FIC), which provides analytic, software, and data management products and services.

The departure of InterActive (formerly USA Interactive) from the portfolio came after S&P downgraded the stock from 5 STARS (strong buy) to 4 STARS (accumulate) on July 9. S&P analyst Scott Kessler says he took a slightly less positive stance on the shares based on risk-reward considerations.

Like all the stocks in the portfolio, Fair Isaac carries our highest investment ranking of 5 STARS. Kessler, who also covers Fair Isaac, believes it represents an appealing investment in the application software sector, and thinks the company's diverse and largely recurring revenue stream will allow for significant revenue and EPS growth despite a sluggish economy and restrained corporate IT budgets.

Based on S&P's

discounted free cash-flow model, Kessler's 12-month price target on the stock is $63.

Year-to-date through June 30, the S&P Top Ten portfolio gained 13.69% vs. an advance of 11.76% for its benchmark, the S&P 500-stock index (both of these performances include dividends).

Here's the latest list:

S&P Top 10 Portfolio

Company

Current Price

(7/10/03 close)

12-Month Target

Investment Rationale

Boston Scientific (BSX)

60.27

70

Explosive growth prospects

Comcast (CMCSA)

31.72

33

Foreign exchange trends, recent share-price drop

Compass Bancshares (CBSS)

35.20

41

Valuation, positive fundamental trends

DR Horton (DHI)

29.59

38

Better-than-expected industry trends

Fair Isaac (FIC)

52.96

63

Attractive valuation

Flextronics (FLEX)

11.45

15

Firming business, low valuation

Jacobs Engineering (JEC)

43.59

48

See strong bookings from refining customers

Martek Biosciences(MATK)

45.94

50

Annual revenue growth of nearly 100% seen through fiscal 2004

Nabors Industries (NBR)

37.90

51

Natural-gas activity expected to rise

Pfizer (PFE)

33.66

38

Trading at a discount to its industry peers

For more information about the Top 10 portfolio, please visit http://www.businessweek.com/investor/content/jun2002/pi20020617_8998.htm By Ken Shea and Robert Gold


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus